Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Capitalist health provision guarantees increasingly worse health outcomes for marginalized populations while creating the conditions for a health bubble collapse. State action is only stabilizing the system through imperialist expansion.

Lee HUMBER 17, former special needs teacher currently working as a tutor in Health and Social Care at Ruskin College, Oxford [“Neoliberalism and the crisis in health and social care,” International Socialism, June 29, 2017, http://isj.org.uk/neoliberalism-and-the-crisis-in-health-and-social-care/]

The huge cost of US healthcare is serviced by individual expenditure, with the average “healthcare consumer” now facing far greater financial exposure to medical costs. Between 2010 and 2015, employees’ contributions to health insurance grew almost three times faster than wages. Recent research showed that so-called “middle class” Americans are feeling this burden the most—their healthcare spending as a percentage of household income has increased 60 percent since the 1990s with their healthcare costs now almost half of a typical mortgage payment.29 Americans are going into debt to service health insurance, spreading health costs to the financial sector more generally.30 This rising cost of healthcare has seen share prices in health-related industries soar. In 2017 three vast health conglomerates were in the top 10 of the US Fortune 500. As a result, US health industries have never been as powerful, or as rich. In the Fortune 500 the three health companies—at numbers five, six and seven—are each richer than former market giants such as General Motors and AT&T. Health market leader McKesson is a pharmaceutical distributor also concerned with the development and distribution of health technologies—a kind of health Walmart. At number six, United Health, largely a health insurance provider has, it is estimated, over 100 million customers globally. An accelerating context of mergers and acquisitions (M&A) has accompanied and further facilitated this process.31 The tendency for capital to evolve into a smaller number of large, industry-specific companies, has been recognised from capitalism’s beginnings and the process is currently very much in evidence in health. Health industry mergers in the US have been accelerating over the last 10 to 15 years, peaking in 2015 and 2016. The total reported deal value of M&A in the US health industry in 2016 was $71.7 billion.32 That was down 59.6 percent from 2015, the record year for M&A in the sector when the figure, in excess of $100 billion, was equivalent to over a third of the total UK GDP for that year.33 This is—on a somewhat smaller scale—a worldwide phenomenon. As I show below, mergers and acquisitions have been actively promoted by UK governments. This growing tendency towards merger in the US as elsewhere is a process of what Karl Marx called the “centralisation of capital”, the coming together of individual capitalists into fewer, larger conglomerates. This article discusses this process in full in the section below looking at the concentration and centralisation of capital in the UK health and social care context. Here, it is important to recognise that the centralisation of capital is an important tendency identified in capital formation in its imperialist phase. In the US the trend towards, and the capitalists’ rationale for actively promoting and pursuing M&A, was outlined at the beginning of the 21st century, when it was argued that “facing the drivers of change—deteriorating public health, poor quality and safety, and unaffordable health care—the industry is poised to experience convergence among the major suppliers”.34 “Poor quality and safety” here refers to the fact that US hospitals increasingly represent a danger to your health. In 2013 medical errors in hospitals were the leading cause of preventable death in the country, accounting for nearly a quarter of all preventable deaths that year, beating smoking and obesity-related illness into second and third place.35 In 2005 it was estimated that there were over 98,000 preventable deaths each year in US hospitals, costing the system over $38 billion annually.36 The point also refers to the seemingly uncontrollable and utterly unethical practices of global drug companies, extensively documented by Ben Goldacre and others, with drug companies routinely hiding data seen as problematic to the development of new drugs, while laws remain largely toothless to prosecute them even if such data and practice is exposed.37 These are some of the, if you like, material reasons put in defence of the ongoing M&A trend. The financial press is littered with claims of the benefits for US workers’ health of the ever-expanding, though fewer in number, health conglomerates.38 Global expansionist sentiment is the other driver of health industry dominance, and capital is currently being sucked into the health industry as never before by the promise of the growing potential of a global health market, which has been called the “Rising Billions”39 This is the idea that, over the next five years, between three and five billion new consumers will be connected to the internet for the first time and are reachable by internet and mobile devices. The rising billions are consumers of goods and services, but are also patients in need of medical care and therefore potential customers for health-related commodities, so called “health customers”. An example of this health technology salesmanship is the “Hemafuse” autotransfusion device. Currently being touted across sub-Saharan Africa and elsewhere, Hemafuse helps patients to deal with internal bleeding, as the advertising literature says “perhaps from a car accident or a complication during pregnancy”.40 In order to survive, patients need to have their blood removed, filtered and returned. As the publicity for Hemafuse claims, the simple device allows even untrained persons safely to treat internal bleeding. No need to call on the services of potentially expensive—or non-existent—health and social care workers, with your own Hemafuse, perhaps bought cheaply via eBay, your next door neighbour could help you with your internal bleeding problems! It sounds ridiculous, but this kind of “blue sky” thinking is currently contributing to the sky-rocketing market in US health industry shares. Technological innovation, fenced by grubby, unscrupulous hucksters, is driving this forward, unsupported by case study, ungoverned by ethical practices of any rigour. Alongside the physical technologies outlined above, eHealth systems are a massive growth area in the US and elsewhere. eHealth covers a broad field including systems of communication between health practitioners: remote health monitoring (many people already use such devices—Fitbit for example—to monitor their own physical wellbeing), and virtual consultations between doctors and other professionals and patients. The list of technologically-driven change seems endless and without boundaries. If we move to virtual consultations then why not use call-centres of doctors based in areas around the world with low labour costs? You can see why the brokers are salivating. Some of the consequences of this technologically-driven approach in the UK context are already evident. Jay Stickland, director of Southwark Council’s adult social care department, is quoted in the Financial Times extolling the virtues of using motion detectors to replace care workers in older people’s homes: “We could pop in [to see someone] at lunchtime, at one o’clock. [But at] five past one, she could be on the floor. So there’s no real value to this”.41 And, of course, once you move to a motion detector system of monitoring patients or service users more broadly, there’s no need for monitoring staff to be in the same borough or city, or even the same country. Why not employ the cheapest staff around the globe, as other industries have already done? Potentially, with a smaller care staff on standby locally, the monitors can raise an alert when a crisis arises in a “just-in-time” approach to healthcare delivery! In later texts, Marx talks about the drive towards technological advance inherent in capitalism, and the labour-saving machinery produced by it potentially eliminating arduous labour for future societies.42 But ­technological advance under capitalism, as Marx was at great pains to point out, primarily aims to replace some workers while increasing the rate of exploitation of those left. Marx describes the three “circumstances” of exploitation rates—the length of the working day, or the extensive magnitude of labour; the intensity of labour, or its intensive magnitude, and the overall productivity of labour.43 In the global health industry, manipulation of all three of these is currently evident, in differing combinations in different geopolitical circumstances, underpinned by and reinforcing austerity, technological changes and the centralisation of capital. The increased potential for a quick profit resulting from this is sucking finance capital into US health like never before. Some commentators at least are uneasy about this: What is larger than the UK’s entire economy, soaring in price, wildly profitable, the leading cause of personal bankruptcy, bankrupting the United States and a massive economic bubble that nobody has heard of yet? Healthcare in America…a modern-day gold rush is on as young Americans clamour for healthcare careers in the same way that young adults were jockeying for technology careers at the peak of the Dot-com bubble in 1999.44 The threat of a health bubble collapse makes previous industry collapses—like those in the US auto and building industries—seem like child’s play in comparison. The US auto industry contributes around 3.5 percent of US GDP and employs 1.7 million people. This industry was deemed “too big to fail” so the US government bailed it out, investing around $80 billion from 2009 to 2014 to keep it from collapsing. Healthcare is five times larger than the auto industry in terms of its percentage contribution to GDP, and is ten times larger in terms of the number of people it employs. It’s estimated that any comparative bail-out of the health industry would cost the government upwards of $400 billion.45 Already, the health industry has a parasitic relationship with the US state, dependent on it to open up new international markets. US military interventions around the globe have made areas “safe” for health industry expansion. Countries including Iraq and Afghanistan, others in the Middle East and parts of Africa are considered regions worthy of US health industry investment.46 Writing in 1917 Nikolai Bukharin wrote: In the epoch of finance capitalism…the centre of gravity is shifted to the competition of gigantic, consolidated and organised economic bodies possessed of a colossal fighting capacity in the world tournament of “nations”. Here competition holds it orgies on the greatest possible scale, and together with this there goes on a change and a shift to a higher phase in the process of capital centralisation. The absorption of small capital units by large ones, the absorption of weak trusts, the absorption even of large trusts by larger ones is relegated to the rear, and looks like child’s play compared with the absorption of whole countries that are being forcibly torn away from their economic centres and included in the economic system of the victorious “nation”.47 The interests of the US state are in many ways already partially fused with those of the US health industry and the finance capital driving its expansion, and together these contextualise an increasingly impoverished home country and the increasing subjugation of foreign lands. Sounds like Victorian Britain. Trump’s “America First” rhetoric and anti-globalisation tone might be perceived as representing a potential threat to the future profitability of these health behemoths, and with it a potential threat to the wellbeing of the US economy itself. A collapse of the US health industry would be disastrous for US capital generally; meanwhile its profitability is teetering on the razor edge of a globalised eHealth promise.

Sign in to recut, update, or save this card.